What are neuroendocrine tumors, and how are they treated? MD Anderson Cancer Center - 23 Feb 2024 What are neuroendocrine tumors, and how are they treated? ... More
Lutathera Delays Growth of Advanced Neuroendocrine Tumors National Cancer Institute (.gov) - 01 Mar 2024 Lutathera Delays Growth of Advanced Neuroendocrine Tumors ... More
FDA Approves Lutathera for Pediatric Patients With SSTR+ Gastroenteropancreatic Neuroendocrine Tumors Pharmacy Times - 23 Apr 2024 FDA Approves Lutathera for Pediatric Patients With SSTR+ Gastroenteropancreatic Neuroendocrine Tumors ... More
Lutathera Approved for Pediatric Patients 12 Years and Older With GEP-NETS Gastroenterology & Endoscopy News - 24 Apr 2024 Lutathera Approved for Pediatric Patients 12 Years and Older With GEP-NETS ... More
Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of ... Nature.com - 23 Apr 2024 Zeb1-controlled metabolic plasticity enables remodeling of chromatin accessibility in the development of ... ... More
Novartis’ Lutathera receives FDA approval to treat neuroendocrine tumours in paediatric patients PMLiVE - 25 Apr 2024 Novartis’ Lutathera receives FDA approval to treat neuroendocrine tumours in paediatric patients ... More
FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine ... Yahoo Finance - 23 Apr 2024 FDA Approves Novartis' Lutathera As First Therapy For Pediatric Patients With Gastroenteropancreatic Neuroendocrine ... ... More
Neuroendocrine Tumors: The Zebra of Cancers - InventUM University of Miami - 11 Oct 2023 Neuroendocrine Tumors: The Zebra of Cancers - InventUM ... More
FDA Approves Lutetium Lu 177 Dotatate for Pediatric SSTR+ GEP-NETs OncLive - 23 Apr 2024 FDA Approves Lutetium Lu 177 Dotatate for Pediatric SSTR+ GEP-NETs ... More
Novartis bags paediatric FDA label expansion for Lutathera Pharmaceutical Technology - 24 Apr 2024 Novartis bags paediatric FDA label expansion for Lutathera ... More
What Are Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)? Everyday Health - 09 Apr 2024 What Are Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)? ... More
Lutathera Approved for Pediatric Patients 12 Years and Older With GEP-NETS Clinical Oncology News - 24 Apr 2024 Lutathera Approved for Pediatric Patients 12 Years and Older With GEP-NETS ... More
FDA Approves First Radioactive Drug for Children With SSTR-Positive GEP-NETs www.oncnursingnews.com/ - 23 Apr 2024 FDA Approves First Radioactive Drug for Children With SSTR-Positive GEP-NETs ... More
Study findings better define the genetic landscape of neuroendocrine tumors of the cervix News-Medical.Net - 17 Apr 2024 Study findings better define the genetic landscape of neuroendocrine tumors of the cervix ... More
Unveiling Novel Therapeutic Targets for Neuroendocrine Cancers: A Precision Medicine Breakthrough Technology Networks - 12 Apr 2024 Unveiling Novel Therapeutic Targets for Neuroendocrine Cancers: A Precision Medicine Breakthrough ... More
World Neuroendocrine Cancer Awareness Day: Discussing Important Advances in Care Targeted Oncology - 10 Nov 2023 World Neuroendocrine Cancer Awareness Day: Discussing Important Advances in Care ... More
NET Tumor Conference to Advance Understanding of Complex, Rare Cancers - InventUM University of Miami - 28 Mar 2024 NET Tumor Conference to Advance Understanding of Complex, Rare Cancers - InventUM ... More
Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors | British ... Nature.com - 10 Feb 2024 Unraveling the impact of cancer-associated fibroblasts on hypovascular pancreatic neuroendocrine tumors | British ... ... More
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with ... Yahoo Finance UK - 23 Apr 2024 Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with ... ... More